[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Steris Corp (STE)

Steris Corp (STE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

STERIS: Can the Infection Control Thesis Survive This Margin Compression?

Steris Corp (STE) reports fiscal Q4 2026 earnings on May 11, 2026, with analysts expecting $2.89 per share—a 5.5% increase from the prior-year quarter. The release comes as the stock trades sharply below all major moving averages amid maximum bearish technical signals, setting up a critical test of whether the medical equipment and sterilization leader can deliver results strong enough to reverse deteriorating sentiment. With the options market pricing a 4.91% expected move and the stock down more than 14% from its 200-day average, this report will determine whether STE can stabilize or faces further downside pressure.

Fundamentals

See More
  • Market Capitalization, $K 20,345,656
  • Shares Outstanding, K 98,075
  • Annual Sales, $ 5,460 M
  • Annual Income, $ 614,640 K
  • EBIT $ 1,049 M
  • EBITDA $ 1,526 M
  • 60-Month Beta 0.95
  • Price/Sales 3.52
  • Price/Cash Flow 14.99
  • Price/Book 2.93

Options Overview Details

View History
  • Implied Volatility 34.64% (+1.60%)
  • Historical Volatility 22.94%
  • IV Percentile 99%
  • IV Rank 97.36%
  • IV High 35.12% on 10/15/25
  • IV Low 16.76% on 08/20/25
  • Expected Move (DTE 5) 10.18 (4.91%)
  • Put/Call Vol Ratio 0.44
  • Today's Volume 36
  • Volume Avg (30-Day) 67
  • Put/Call OI Ratio 1.31
  • Today's Open Interest 1,999
  • Open Int (30-Day) 1,785
  • Expected Range 197.27 to 217.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $2.86
  • Number of Estimates 2
  • High Estimate $2.86
  • Low Estimate $2.85
  • Prior Year $2.74
  • Growth Rate Est. (year over year) +4.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
195.14 +6.31%
on 05/07/26
227.87 -8.96%
on 04/21/26
-17.58 (-7.81%)
since 04/08/26
3-Month
195.14 +6.31%
on 05/07/26
255.66 -18.86%
on 02/26/26
-44.71 (-17.73%)
since 02/06/26
52-Week
195.14 +6.31%
on 05/07/26
269.44 -23.01%
on 01/16/26
-18.41 (-8.15%)
since 05/08/25

Most Recent Stories

More News
STERIS: Can the Infection Control Thesis Survive This Margin Compression?

Barchart Research What to Expect from STE Earnings STE Generated May 8, 2026 Current Price $207.45 EPS Estimate $$2.89 Consensus Rating Moderate Buy Average Move 5.91% STERIS: Can the Infection Control...

STE : 207.45 (-2.92%)
What To Expect From STERIS’s (STE) Q1 Earnings

What To Expect From STERIS’s (STE) Q1 Earnings

STE : 207.45 (-2.92%)
STERIS: Can the Infection Control Thesis Survive This Margin Compression?

Barchart Research What to Expect from STE Earnings STE Generated May 8, 2026 Current Price $207.45 EPS Estimate $$2.89 Consensus Rating Moderate Buy Average Move 5.91% STERIS: Can the Infection Control...

STE : 207.45 (-2.92%)
STERIS: Can the Infection Control Thesis Survive This Margin Compression?

Barchart Research What to Expect from STE Earnings STE Generated May 8, 2026 Current Price $207.45 EPS Estimate $$2.89 Consensus Rating Moderate Buy Average Move 5.91% STERIS: Can the Infection Control...

STE : 207.45 (-2.92%)
STERIS Appoints Pierre Boulud to Board of Directors

DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board...

STE : 207.45 (-2.92%)
3 Healthcare Stocks Walking a Fine Line

3 Healthcare Stocks Walking a Fine Line

OPCH : 20.51 (-1.16%)
STE : 207.45 (-2.92%)
SGRY : 14.44 (+0.91%)
7 Stocks Worth Buying the Dip in Now... Or At Least Adding to Your Watchlist

While the S&P 500 notched another record close on Tuesday, 17 NYSE and Nasdaq Composite stocks fell to new 52-week lows. Here’s why the seven highest-priced names deserve a spot on your watchlist.

UFPT : 230.55 (+4.16%)
SYK : 285.47 (-2.98%)
SBUX : 104.93 (+0.64%)
STE : 207.45 (-2.92%)
POOL : 187.77 (-1.40%)
HD : 317.45 (-1.61%)
KNSL : 304.87 (-1.28%)
MCD : 275.75 (-2.80%)
STERIS Announces Dividend of $0.63 per share

DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share....

STE : 207.45 (-2.92%)
STERIS (STE): Buy, Sell, or Hold Post Q4 Earnings?

STERIS (STE): Buy, Sell, or Hold Post Q4 Earnings?

STE : 207.45 (-2.92%)
1 Profitable Stock for Long-Term Investors and 2 We Brush Off

1 Profitable Stock for Long-Term Investors and 2 We Brush Off

STE : 207.45 (-2.92%)
NOG : 23.40 (-2.21%)
IPAR : 94.48 (+0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS...

See More

Key Turning Points

3rd Resistance Point 219.51
2nd Resistance Point 216.90
1st Resistance Point 212.18
Last Price 207.45
1st Support Level 204.85
2nd Support Level 202.24
3rd Support Level 197.52

See More

52-Week High 269.44
Fibonacci 61.8% 241.06
Fibonacci 50% 232.29
Fibonacci 38.2% 223.52
Last Price 207.45
52-Week Low 195.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.